<?xml version="1.0" encoding="UTF-8"?><rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
> <channel><title>Comments on: Dyadic founder fights to regain control of company</title> <atom:link href="http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/feed/" rel="self" type="application/rss+xml" /><link>http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/</link> <description>Commercial, legal, political, and scientific trends in biotechnology</description> <lastBuildDate>Wed, 03 Mar 2010 20:01:20 +0000</lastBuildDate> <generator>http://wordpress.org/?v=2.9.1</generator> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <item><title>By: smaranya.com &#187; Blog Archive &#187; Dyadic founder regains control</title><link>http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-6016</link> <dc:creator>smaranya.com &#187; Blog Archive &#187; Dyadic founder regains control</dc:creator> <pubDate>Tue, 01 Jul 2008 10:23:09 +0000</pubDate> <guid
isPermaLink="false">http://www.biotechblog.com/?p=600#comment-6016</guid> <description>[...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]</description> <content:encoded><![CDATA[<p>[...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]</p> ]]></content:encoded> </item> <item><title>By: Biotech Blog &#124; Dyadic founder regains control</title><link>http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-6015</link> <dc:creator>Biotech Blog &#124; Dyadic founder regains control</dc:creator> <pubDate>Mon, 30 Jun 2008 13:07:58 +0000</pubDate> <guid
isPermaLink="false">http://www.biotechblog.com/?p=600#comment-6015</guid> <description>[...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]</description> <content:encoded><![CDATA[<p>[...] an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by [...]</p> ]]></content:encoded> </item> <item><title>By: Mac</title><link>http://www.biotechblog.com/2008/05/11/dyadic-founder-fights-to-regain-control-of-company/comment-page-1/#comment-5954</link> <dc:creator>Mac</dc:creator> <pubDate>Sun, 01 Jun 2008 18:51:29 +0000</pubDate> <guid
isPermaLink="false">http://www.biotechblog.com/?p=600#comment-5954</guid> <description>I think in this case the one who lost the most is the former CEO Mark Emalfarb, because his dignity was in the stake. He was asked to voluntary resign from its board and was found acused of concealing facts.</description> <content:encoded><![CDATA[<p>I think in this case the one who lost the most is the former CEO Mark Emalfarb, because his dignity was in the stake. He was asked to voluntary resign from its board and was found acused of concealing facts.</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (user agent is rejected)
Database Caching 8/18 queries in 1.184 seconds using disk

Served from: www.biotechblog.com @ 2010-03-19 00:50:25 -->